Sydney Jennings

Patient Care

New CVD Risk Model Flags Heart Disease Earlier in Reproductive-Age Women

By: Sydney Jennings

A McGill University–led team developed a prediction model integrating pregnancy-related factors to identify cardiovascular disease risk in women aged 15 to 45.

Patient Care

New Childhood Vaccine Executive Order Draws Criticism From AAP, AMA, NFID

By: Abigail Brooks

The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.

Patient Care

Once-Weekly Insulin Icodec Enters US Market for Adults With Type 2 Diabetes

By: Abigail Brooks

Insulin icodec is now available in the US after FDA approval, offering adults with type 2 diabetes a once-weekly basal insulin option.

Patient Care

Avexitide Reduced Hypoglycemic Events in Phase 3 Post-Bariatric Hypoglycemia Trial

By: Abigail Brooks

Phase 3 LUCIDITY results showed avexitide reduced Level 2 and Level 3 hypoglycemic events by 55% vs placebo in post-bariatric hypoglycemia.

Patient Care

FDA Approves Garetosmab for Adults With Fibrodysplasia Ossificans Progressiva

By: Abigail Brooks

FDA approved garetosmab for adults with FOP after phase 3 data showed fewer new HO lesions and clinician-assessed flare-ups vs placebo.

Patient Care

FDA Authorizes First Wearable Device to Continuously Monitor Glucose, Ketones

By: Sydney Jennings

FDA authorized Abbott’s Libre Duo 10 Day system, the first wearable device to continuously monitor both glucose and ketones.

Patient Care

Physical Activity May Reduce Stroke and Mortality Risk in Persons With Atrial Fibrillation

By: Sydney Jennings

Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.

Patient Care

5 FDA Decisions for Primary Care to Know from August 2026

By: Abigail Brooks

Recent FDA actions include updates in HIV, influenza, narcolepsy, type 2 diabetes, and RSV prevention in high-risk children.

Patient Care

FDA Approves Pfizer-BioNTech XFG-Adapted COVID-19 Vaccine for 2026-27 Season

By: Sydney Jennings

FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.

Patient Care

Semaglutide Improves BMI Category in Phase 3 Pediatric Obesity Trial

By: Abigail Brooks

Semaglutide brought 40.4% of children below the obesity BMI threshold, according to top-line results from the phase 3 STEP Young clinical trial.